Evidence map›Paper›PMID 34919420›Full record

ArticleThe British journal of radiology2022

The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons.

Maria Cristina Leonardi, Andriana Kouloura, Damaris Patricia Rojas, Mattia Zaffaroni, Mattia Intra, Paolo Veronesi, Anna Morra, Marianna Alessandra Gerardi, Cristiana Iuliana Fodor, Maria Alessia Zerella and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Maria Cristina LeonardiDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Andriana KoulouraDivision of Breast Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Damaris Patricia RojasDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-8074-5042
Mattia ZaffaroniDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Mattia IntraDivision of Breast Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Paolo VeronesiDivision of Breast Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Anna MorraDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Marianna Alessandra GerardiDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Cristiana Iuliana FodorDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Maria Alessia ZerellaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Anna Maria CamardaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Federica CattaniUnit of Medical Physics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Rosa LuraschiUnit of Medical Physics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Anna ViolaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Giulia RivaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Eleonora MigliettaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Roberto OrecchiaScientific Direction, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Samantha DicuonzoDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Barbara Alicja Jereczek-FossaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
European Institute of Oncology · ITUniversity of Milan · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITNational Center for Oncological Hadrontherapy · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study is to evaluate feasibility of salvage 4-week hypofractionated whole breast radiotherapy (WBRT) in patients with in-breast recurrence after receiving intraoperative radiotherapy with electrons (IOERT) for primary breast cancer (BC).

methodsBC patients who had repeated quadrantectomy underwent modified WBRT with intensity-modulated radiotherapy using Helical Tomotherapy to underdose the IOERT region. This approach, called POLO (Partially Omitted Lobe), excluded the IOERT volume from receiving the full prescription dose.

resultsNine patients were treated with this approach, receiving 45 Gy in 20 fractions. A simultaneous integrated boost of 2.5 Gy in 20 fractions was delivered in 6/9 patients. Dose constraints and planning objectives were reported. No severe toxicity was reported while local control and overall survival were 100%.

conclusionThe POLO approach is technically feasible and capable to achieve a significant reduction of radiation dose delivered to the previous treated IOERT area. ADVANCES IN KNOWLEDGE: The study demonstrates the technical and dosimetric feasibility of conservative salvage whole breast radiotherapy, while sparing the area already treated with IORT, in patients with in-breast recurrence.

Indexed as

Breast NeoplasmsRadiotherapy, Intensity-ModulatedElectronsFemaleHumansMastectomy, SegmentalRadiotherapy, AdjuvantRadiotherapy Dosage

Identifiers

PMID34919420
PMCPMC9153727
OpenAlexW4200079727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.